Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 464

Similar articles for PubMed (Select 21631494)

1.

A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.

Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R.

Headache. 2011 Jul-Aug;51(7):1078-86. doi: 10.1111/j.1526-4610.2011.01910.x. Epub 2011 Jun 1.

PMID:
21631494
2.

Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.

Cady RK, Schreiber CP, Beach ME, Hart CC.

Med Sci Monit. 2005 Sep;11(9):PI65-9. Epub 2005 Aug 26.

PMID:
16127373
3.

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH; Investigators.

Cephalalgia. 2002 Sep;22(7):523-32.

PMID:
12230594
4.

Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.

Tuchman M, Hee A, Emeribe U, Silberstein S.

CNS Drugs. 2006;20(12):1019-26.

PMID:
17140280
5.
6.

Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.

Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.

Headache. 2012 Apr;52(4):530-43. doi: 10.1111/j.1526-4610.2011.02039.x. Epub 2011 Nov 21.

PMID:
22103635
7.
8.

Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.

Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.

Headache. 2006 Jan;46(1):115-24.

PMID:
16412159
9.
10.
11.
12.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
13.

A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.

Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.

Headache. 2009 Jun;49(6):826-37. doi: 10.1111/j.1526-4610.2009.01453.x.

PMID:
19545249
14.

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.

Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R; Rizatriptan Protocol 059 and 061 Study Groups.

Headache. 2004 Oct;44(9):891-9.

PMID:
15447698
15.

Long-term efficacy and tolerability of rizatriptan wafers in migraine.

Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C; Rizatriptan-RPD Study Group.

MedGenMed. 2001 Jun 1;3(3):1.

18.

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ; AEGIS Investigator Study Group.

Headache. 2007 Feb;47(2):189-98.

PMID:
17300358
19.

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.

Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27.

PMID:
19486178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk